Oneness Biotech Co., Ltd. 4743

TPEX · Taiwan · Health Technology

TWD 46.00+0.15 (+0.33%)

Market open· Oct 2, 2026, 2:30 AM UTC· TWD · Data may be delayed

Company news

Yahoo FinanceSep 29, 2026

Oneness Biotech Advances SNS851 to Phase 1 Multiple-Ascending Dose Evaluation for Obesity-Associated Metabolic Diseases

TAIPEI CITY, Taiwan, September 29, 2026--Oneness Biotech completed the SAD portion of its Phase 1 trial evaluating SNS851 as a potential treatment for obesity-associated metabolic diseases.

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.

Prices may be delayed and are for informational purposes only - not investment advice.